Dr. Jeffrey Morgan Discusses the Reality of Bioprinted Hearts for Patients With Advanced Heart Failure

Dr. Jeffrey A. Morgan is Cardiac Surgeon Specializing in the Treatment of Advanced Heart Failure with Mechanical Assist Devices and Heart Transplantation; Dr. Morgan Strives to Contribute Innovative Solutions to the Medical Field and Works Diligently to Provide His Patients with a Superior Level of Care

HOUSTON, TX / ACCESSWIRE / June 25, 2019 / Cardiac surgeon and Chief Medical Officer for BIOLIFE4D – Dr. Jeffrey Morgan was recently featured on the Futuretech Podcast, where he provided a comprehensive overview of surgical therapies currently being utilized to treat heart failure.

The Futuretech podcast features exclusive innovations that are poised to transform our lives for the better. The podcast entails conversations which are led by industry experts to create an educational dialogue for up and coming technological trends effecting a wide range of industries. Futuretech focuses subject matter which includes artificial intelligence (AI), 3D printing, regenerative medicine, blockchain, and virtual reality.

In this episode, Dr. Morgan discusses the causes of heart failure and examines the positive and negative aspects of various surgical therapies currently available including total artificial heart (TAH) and left ventricular assist devices (LVADS).

He also details the future direction of bioprinted hearts and explains how 3D bioprinting has the potential to transform the medical field. The plan is for bioprinting to create functional biological structures with the potential to restore, improve, or replace existing organ function.

Dr. Jeffrey Morgan explains how these transformative medical benefits could potentially ultimately eliminate the rejection of transplanted organs by utilizing a patient’s cells to create the organ. Additionally, the use of bioprinting would decrease the wait time for donated organs and minimize the need to obtain organs from donors.

To listen to this podcast please visit https://www.futuretechpodcast.com/podcasts/growing-beating-hearts-from-cells-dr-jeffrey-a-morgan-chief-medical-officer-for-biolife4d/

About Dr. Jeffrey Morgan

Dr. Morgan is a cardiac surgeon who specializes in adult cardiac surgery and performs coronary artery bypass grafting, mitral valve repair/replacement, aortic valve replacement, implantation of LVADs, artificial hearts, and heart transplantation. He trained at New York University for cardiac surgery followed by advanced training at Columbia Presbyterian Medical Center for advanced heart failure – LVADs and heart transplants.

Contact:

Dr. Jeffrey Morgan
info@drjeffreymorgan.live

SOURCE: Dr. Jeffrey Morgan

View source version on accesswire.com:
https://www.accesswire.com/549801/Dr-Jeffrey-Morgan-Discusses-the-Reality-of-Bioprinted-Hearts-for-Patients-With-Advanced-Heart-Failure

user

Recent Posts

Skanska expands hospital in Astoria, Oregon, USA for USD 74M, about SEK 780M

STOCKHOLM, July 15, 2024 /PRNewswire/ -- Skanska has signed a contract with Columbia Memorial Hospital…

1 hour ago

Encision Reports Fourth Quarter Fiscal Year 2024 Results

BOULDER, CO / ACCESSWIRE / July 15, 2024 / Encision Inc. (OTCPK:ECIA), a medical device…

1 hour ago

Teknova Announces Closing of $15.4 Million Private Placement

HOLLISTER, Calif., July 12, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a…

2 days ago

Faith In Young Champions: Hisense Partners with UEFA Foundation to Bring the Beautiful Game to Hospitalized Children

QINGDAO, China, July 12, 2024 /PRNewswire/ -- During the EURO 2024 tournament, the global home…

2 days ago

JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS

LAS VEGAS, July 12, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN), a multidisciplinary organization with…

2 days ago

Hospital Español Auxilio Mutuo De Puerto Rico, Inc. Reports Network Breach

Important Notice About a Privacy MatterSAN JUAN, PUERTO RICO / ACCESSWIRE / July 12, 2024…

2 days ago